Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Investing Activities (2016 - 2025)

Cross Country Healthcare's Cash from Investing Activities history spans 16 years, with the latest figure at -$2.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 16.36% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$8.2 million, up 6.35%, while the annual FY2025 figure was -$8.2 million, 6.35% up from the prior year.
  • Cash from Investing Activities reached -$2.1 million in Q4 2025 per CCRN's latest filing, up from -$2.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$1.1 million in Q3 2024 to a low of -$37.1 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$5.4 million, with a median of -$2.4 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: crashed 1620.29% in 2021, then soared 93.33% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$4.7 million in 2021, then tumbled by 691.95% to -$37.1 million in 2022, then soared by 92.25% to -$2.9 million in 2023, then rose by 11.97% to -$2.5 million in 2024, then rose by 16.36% to -$2.1 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Cash from Investing Activities are -$2.1 million (Q4 2025), -$2.2 million (Q3 2025), and -$2.0 million (Q2 2025).